These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 11781595)

  • 1. Vancomycin monitoring in term newborns: comparison of peak and trough serum concentrations determined by high performance liquid chromatography and fluorescence polarization immunoassay.
    Feferbaum R; Kobol Machado JK; de Albuquerque Diniz EM; Okay TS; Santos SR; Ceccon ME; Krebs VL; de Araújo MC; Costa Vaz A
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(5):149-52. PubMed ID: 11781595
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monitoring the treatment of sepsis with vancomycin in term newborn infants.
    Machado JK; Feferbaum R; Diniz EM; Okay TS; Ceccon ME; Costa Vaz FA
    Rev Hosp Clin Fac Med Sao Paulo; 2001; 56(1):17-24. PubMed ID: 11378679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. New modified fluorescence polarization immunoassay does not falsely elevate vancomycin concentrations in patients with end-stage renal disease.
    Smith PF; Petros WP; Soucie MP; Copeland KR
    Ther Drug Monit; 1998 Apr; 20(2):231-5. PubMed ID: 9558140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Monitoring serum vancomycin concentrations in the treatment of Staphylococcus infections in children].
    Mariani-Kurkdjian P; Nebbad H; Aujard Y; Bingen E
    Arch Pediatr; 2008 Nov; 15(11):1625-9. PubMed ID: 18848438
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interference with vancomycin fluorescence polarisation immunoassay in a nonuraemic patient.
    Bowhay S; Timms P
    Ther Drug Monit; 1997 Feb; 19(1):117-9. PubMed ID: 9029761
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of high-performance liquid chromatography with fluorescence polarization immunoassay for the analysis of vancomycin in patients with chronic renal failure.
    Najjar TA; al-Dhuwailie AA; Tekle A
    J Chromatogr B Biomed Appl; 1995 Oct; 672(2):295-9. PubMed ID: 8581137
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of bioassay, high-performance liquid chromatography, and fluorescence polarization immunoassay for quantitative determination of vancomycin in serum.
    Ristuccia PA; Ristuccia AM; Bidanset JH; Cunha BA
    Ther Drug Monit; 1984; 6(2):238-42. PubMed ID: 6377600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overestimation of vancomycin concentrations utilizing fluorescence polarization immunoassay in patients on peritoneal dialysis.
    Morse GD; Nairn DK; Bertino JS; Walshe JJ
    Ther Drug Monit; 1987 Jun; 9(2):212-5. PubMed ID: 3617161
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An improved micromethod for vancomycin determination by high-performance liquid chromatography.
    Li L; Miles MV; Hall W; Carson SW
    Ther Drug Monit; 1995 Aug; 17(4):366-70. PubMed ID: 7482691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of vancomycin in renally impaired patient samples using a new high-performance liquid chromatography method with vitamin B12 internal standard: comparison of high-performance liquid chromatography, emit, and fluorescence polarization immunoassay methods.
    Hu MW; Anne L; Forni T; Gottwald K
    Ther Drug Monit; 1990 Nov; 12(6):562-9. PubMed ID: 2275003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Rapid serum vancomycin assay by high-performance liquid chromatography using a semipermeable surface packing material column.
    Furuta I; Kitahashi T; Kuroda T; Nishio H; Oka C; Morishima Y
    Clin Chim Acta; 2000 Nov; 301(1-2):31-9. PubMed ID: 11020460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Instability of standard calibrators may be involved in overestimating vancomycin concentrations determined by fluorescence polarization immunoassay.
    Morishige H; Shuto H; Ieiri I; Otsubo K; Oishi R
    Ther Drug Monit; 1996 Feb; 18(1):80-5. PubMed ID: 8848826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of an automated fluorescence polarization immunoassay for vancomycin.
    Filburn BH; Shull VH; Tempera YM; Dick JD
    Antimicrob Agents Chemother; 1983 Aug; 24(2):216-20. PubMed ID: 6357070
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development and validation of a new ultra-performance liquid chromatographic method for vancomycin assay in serum and its application to therapeutic drug monitoring.
    Cao Y; Yu J; Chen Y; Zhang J; Wu X; Zhang Y; Li G
    Ther Drug Monit; 2014 Apr; 36(2):175-81. PubMed ID: 24216537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overestimation of serum vancomycin concentrations using a fluorescence polarization immunoassay (Tdx) in preterm neonates.
    Paap CM; Sharpe GL
    Dev Pharmacol Ther; 1993; 20(3-4):174-9. PubMed ID: 7828450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vancomycin serum concentrations in patients with renal dysfunction: a comparison of fluorescence polarization immunoassay and the enzyme-multiplied immunoassay technique.
    Peckman HJ; Dupuis RE; Sawyer WT; Brouwer KL; Cross RE
    Ther Drug Monit; 1996 Dec; 18(6):647-53. PubMed ID: 8946660
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dose regimen for vancomycin not needing serum peak levels?
    Tan WH; Brown N; Kelsall AW; McClure RJ
    Arch Dis Child Fetal Neonatal Ed; 2002 Nov; 87(3):F214-6. PubMed ID: 12390995
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vancomycin assay performance in patients with acute renal failure.
    Trujillo TN; Sowinski KM; Venezia RA; Scott MK; Mueller BA
    Intensive Care Med; 1999 Nov; 25(11):1291-6. PubMed ID: 10654216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vancomycin population pharmacokinetics in neonates.
    de Hoog M; Schoemaker RC; Mouton JW; van den Anker JN
    Clin Pharmacol Ther; 2000 Apr; 67(4):360-7. PubMed ID: 10801244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of a quantitative vancomycin immunoassay for the Abbott AxSYM analyzer.
    Adamczyk M; Brate EM; Chiappetta EG; Ginsburg S; Hoffman E; Klein C; Perkowitz MM; Rege SD; Chou PP; Costantino AG
    Ther Drug Monit; 1998 Apr; 20(2):191-201. PubMed ID: 9558134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.